Skip to main content

Advertisement

Log in

Fatal Strongyloides hyper-infection in a patient with myasthenia gravis

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

We report a fatal case of Strongyloides hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis.

Case presentation

Our patient was a farmer with a past history of living in an endemic area for Strongyloides stercoralis in Iran. Hyper-infection was diagnosed during the advanced-stage disease by demonstration of enormous number of larvae in the direct smears prepared from both the stool and tracheal secretions. Unfortunately, despite appropriate anti-parasite therapy, the patient died due to respiratory failure.

Conclusion

We recommend the provision of more awareness in high-risk people prior to immunosuppressive therapy, through screening for S. stercoralis, even in non-endemic regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Hakim SZ, Genta RM. Fatal disseminated strongyloidiasis in a vietnam war veteran. Arch Pathol Lab Med. 1986;110:809–12.

    CAS  PubMed  Google Scholar 

  2. Sasaki Y, Tanigushi T, Kinjo M, McGill RL, McGill AT, Tsuha S, Shiiki S. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. Infection. 2013;41:1189–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Al-Hasan MN, McCormick M, Ribes JA. Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007;128:622–7.

    Article  PubMed  Google Scholar 

  4. Moghadam KG, Khashayar P, Hashemi M. Gastrointestinal strongyloidiasis in immunocompromised patients: a case report. Acta Med Indones. 2011;43:191–4.

    PubMed  Google Scholar 

  5. Yassin MA, El Omri H, Al-Hijji I, Taha R, Hassan R, Aboudi KA, El-Ayoubi H. Fatal Strongyloides stercoralis hyperinfection in a patient with multiple myeloma. Braz J Infect Dis. 2010;14:536–9.

    Article  PubMed  Google Scholar 

  6. Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK, Craft N. Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol. 2010;63:896–902.

    Article  PubMed  Google Scholar 

  7. Mokaddas EM, Shati S, Abdulla A, Nampoori NR, Iqbal J, Nair PM, et al. Fatal strongyloidiasis in three kidney recipients in Kuwait. Med Princ Pract. 2009;18:414–7.

    Article  PubMed  Google Scholar 

  8. Vilela EG, Clemente WT, Mira RR, Torres HO, Veloso LF, Fonseca LP, et al. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis. 2009;11:132–6.

    Article  CAS  PubMed  Google Scholar 

  9. Bava AJ, Troncoso AR. Strongyloides stercoralis hyperinfection in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic). 2009;8:235–8.

    Article  Google Scholar 

  10. Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11:143–8.

    Article  CAS  PubMed  Google Scholar 

  11. Kia EB, Rahimi HR, Mirhendi H, Nilforoushan MR, Talebi A, Zahabiun F, et al. A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate. Korean J Parasitol. 2008;46:261–3.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102:283–95.

    Article  CAS  PubMed  Google Scholar 

  13. Ashrafi K, Tahbaz A, Rahmati B. Strongyloides stercoralis: the most prevalent parasitic cause of eosinophilia in gilan province. Northern Iran. Iran J Parasitol. 2010;5:40–7.

    CAS  Google Scholar 

  14. Fardet L, Généreau T, Poirot JL, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54:18–27.

    Article  PubMed  Google Scholar 

  15. Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol. 2005;39:203–11.

    Article  PubMed  Google Scholar 

  16. Nagalotimath SJ, Ramaprasad AV, Chandrashekhar NK. Fatal strongyloidiasis in a patient receiving corticosteroids. Indian J Pathol Bacteriol. 1974;17:190–2.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Ali-Asghar Pahlevan for the time generously spent in thoroughly revising the manuscript.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Bijani.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saraei, M., Hosseinbigi, B., Shahnazi, M. et al. Fatal Strongyloides hyper-infection in a patient with myasthenia gravis. Infection 42, 1039–1042 (2014). https://doi.org/10.1007/s15010-014-0637-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-014-0637-x

Keywords

Navigation